Compare Amylx Pharmaceuticals Inc (AMLX) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Keysight Technologies Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Keysight Technologies Inc trades at $351 (market cap $58.74B). The key difference: Keysight Technologies Inc is far larger — about 22.3× Amylx Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMLX | KEYS | |
|---|---|---|
Market Cap | $2.64B | $58.74B |
Sector | Health | Technology |
52-Week High | $24.19 | $373.34 |
52-Week Low | $7.82 | $158.51 |
Enterprise Value | $2.39B | $59.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
